• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

[title missed]

DOI: 10.12201/bmr.202507.00074
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: 随着透析龄的逐渐延长,尿毒症毒素的积累,腹腔内导管的机械刺激,长期接触生物不相容性透析液,慢性心力衰竭、代谢性酸中毒、胰岛素抵抗等能造成PD患者持续微炎症状态。微炎症是一种持续的低水平炎症状态,临床表现为炎症因子水平升高,长期持续的微炎症状态进一步导致PD患者预后不良。β2-MG在PD患者中的积累被认为是引发微炎症状态的重要因素之一,其作用机制涉及多个途径和分子通路。研究证明β2-MG通过非经典转化生长因子-β(Transforming growth factor-β, TGF β ) , 激活单核细胞中的TGF-β信号传导,促使其向M1型巨噬细胞分化并分泌肿瘤坏死因子- α(Tumor necrosis factor- α, TNF- α ) 、白介素-1 β( Interleukin-1 β, IL-1 β ) 以及白介素-6(Interleukin-6, IL-6)等炎性因子5,这些促炎因子通过自分泌或旁分泌机制活化NF-κB通路,进一步刺激腹膜细胞,加剧局部和全身炎症反应。Heiko Bruns等人将研究聚焦到β2-MG与炎症小体上,从体内外实验证明了β2-MG作为一种被巨噬细胞吞噬后的内源性介质,会形成淀粉样纤维,这使得溶酶体肿胀破裂,激活NLRP3炎性小体,进而促使IL-1β和IL-18分泌过度,表明β2-MG代表巨噬细胞无菌炎症的诱导剂6。既往研究表明氧化应激反应可以加剧炎症反应,PD患者早期肾功能衰竭有氧化应激反应参与,长期持续的氧化应激反应导致持续的微炎症反应。研究表明,β2-MG可以作为氧化应激的新型生物标志物7,有学者将120例早期2型糖尿病肾病患者纳入研究,发现β2-MG水平与早期2型糖尿病肾病患者氧化应激程度呈正相关8。有研究结果表明抑制β2-MG有助于增加抗氧化物的含量,能够降低氧化应激的产生和相关因子的释放,从而缓解氧化应激对肾损伤的影响9。由此可见,β2-MG通过加剧氧化应激反应促进患者全身微炎症反应,由此推断,这种现象在PD患者中表现得更明显。

    Key words: ; ; ; 

    Submit time: 27 July 2025

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • 李洛华. . 2025. doi: 10.12201/bmr.202506.00031

    Shen Yanping. Research progress of peritoneal transport function and microinflammation. 2024. doi: 10.12201/bmr.202412.00066

    DuYuPeng, LinYan. Exploration of Diagnostic and Treatment Experience in Two Cases of Idiopathic Retroperitoneal Fibrosis. 2024. doi: 10.12201/bmr.202410.00077

    Zhang Ye, Yang Li. The experience of American peritoneal dialysis favored policy and its enlightenment to China. 2022. doi: 10.12201/bmr.202206.00011

    莫先阳, guo yi ting, wang nan, ying chang jiang. Correlation between Serum DAPK1 and T-tau Protein Levels and Cognitive ImPairment in Patients with TyPe 2 Diabetes. 2025. doi: 10.12201/bmr.202506.00038

    Clinical application of magnetic resonance imaging technology in cognitive dysfunction after stroke. 2024. doi: 10.12201/bmr.202411.00056

    Lin ZhiFeng, ZHANG ChuJian, LIU Dong, Kong YiJing. To explore the optimal intervention time of 1.25 (OH) 2D3 to protect renal interstitialfibrosis based on NF-κB inflammatory pathway. 2025. doi: 10.12201/bmr.202504.00063

    Zhang Jie, Lu Yuyu, Wang Pengjun, Han Jianhong. The Role of Inflammation-Mediated Endothelial Dysfunction and Blood-Brain Barrier Disruption in Cerebral Microbleeds. 2025. doi: 10.12201/bmr.202504.00045

    zhaofenqin. . 2025. doi: 10.12201/bmr.202501.00040

    shenzhouji, guofei. Research progress of histone modification and DNA methylation in diabetes nephropathy. 2024. doi: 10.12201/bmr.202407.00011

  • ID Submit time Number Download
    1 2025-07-03

    bmr.202507.00074V1

    Download
  • Public  Anonymous  To author only

Get Citation

[authors missed]. [title missed]. 2025. biomedRxiv.202507.00074

Article Metrics

  • Read: 41
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误